Stocks and Investing
Stocks and Investing
Thu, September 19, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, September 18, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Edward White Reiterated (TGTX) at Strong Buy and Held Target at $49 on, Sep 18th, 2024
Edward White of HC Wainwright & Co., Reiterated "TG Therapeutics, Inc." (TGTX) at Strong Buy and Held Target at $49 on, Sep 18th, 2024.
Edward has made no other calls on TGTX in the last 4 months.
There are 2 other peers that have a rating on TGTX. Out of the 2 peers that are also analyzing TGTX, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Corinne Jenkins of "Goldman Sachs" Maintained at Hold with Increased Target to $20 on, Wednesday, August 7th, 2024
This is the rating of the analyst that currently disagrees with Edward
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $34 on, Wednesday, August 7th, 2024
Contributing Sources